Sequencing bispecific antibodies and CAR T cell therapy in multiple myeloma with prior exposure to BCMA-targeted therapies.

被引:0
|
作者
Patel, Urvi
Oluwole, Olalekan O.
Kassim, Adetola
Jayani, Reena
Belliveau, Paul
Savani, Bipin
Dholaria, Bhagirathbhai R.
机构
[1] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Massachusetts Coll Pharm & Hlth Sci, Worcester, MA USA
[4] Vanderbilt Ingram Canc Ctr, Div Hematol & Oncol, Nashville, TN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e20049
引用
收藏
页数:1
相关论文
共 50 条
  • [21] BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
    Smith, Eric L.
    Mailankody, Sham
    Staehr, Mette
    Wang, Xiuyan
    Senechal, Brigitte
    Purdon, Terence J.
    Daniyan, Anthony F.
    Geyer, Mark B.
    Goldberg, Aaron D.
    Mead, Elena
    Santomasso, Bianca D.
    Landa, Jonathan
    Rimner, Andreas
    Riviere, Isabelle
    Landgren, Ola
    Brentjens, Renier J.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (07) : 1047 - 1053
  • [22] Current status of bispecific antibodies and CAR-T therapies in multiple myeloma
    Szlasa, Wojciech
    Dybko, Jaroslaw
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134
  • [23] BCMA-targeted therapies for multiple myeloma: strategies to maximize efficacy and minimize adverse events
    Watson, Edmund
    Djebbari, Faouzi
    Rampotas, Alexandros
    Ramasamy, Karthik
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (06) : 503 - 517
  • [24] T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA
    van de Donk, Niels W. C. J.
    O'Neill, Chloe
    de Ruijter, Maaike E. M.
    Verkleij, Christie P. M.
    Zweegman, Sonja
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (06) : 601 - 611
  • [25] Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy
    Hill, Joshua A.
    Kiem, Erika S.
    Bhatti, Atif
    Liu, Winnie
    Keane-Candib, Jacob
    Fitzpatrick, Kristin S.
    Boonyaratanakornkit, Jim
    Gardner, Rebecca A.
    Green, Damian J.
    Maloney, David G.
    Turtle, Cameron J.
    Smith, Jodi M.
    Gimferrer, Idoia
    Blosser, Christopher D.
    Jackson, Shaun W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (03) : 416 - 422
  • [26] Overcoming Challenges: Development of Two Potent, Domestic BCMA-targeted CAR-T Cell Products for the Treatment of Multiple Myeloma in Brazil
    Suzuki, Caroline
    Mitsugi, Thiago
    Andrade, Gislaine
    Vidal, Erica
    Barros, Cleyson
    Zanetti, Larissa
    Azevedo, Julia
    Paiva, Raquel
    Okamoto, Oswaldo
    Hamerschlak, Nelson
    Kerbauy, Lucila
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S91 - S91
  • [27] Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma
    Duvalyan, Eva
    Shah, Nina
    Lo, Mimi
    Martin III, Thomas
    Wolf, Jeffrey L.
    Chung, Alfred
    Arora, Shagun
    Huang, Chiung-Yu
    Wong, Sandy W.
    LEUKEMIA & LYMPHOMA, 2023,
  • [28] Patient perspectives on BCMA-targeted therapies for multiple myeloma: a survey conducted in a patient advocacy group
    Hydren, Jay R.
    Lin, Dee
    Sweeney, Nathan W.
    Wu, Bingcao
    Kim, Nina
    Patel, Saurabh
    Sborov, Douglas W.
    Berdeja, Jesus G.
    Anderson Jr, Larry D.
    Huo, Stephen
    Martinez, Jorge Arturo Hurtado
    Ahlstrom, Jennifer M.
    FRONTIERS IN HEALTH SERVICES, 2024, 4
  • [29] Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma
    Duvalyan, Eva
    Shah, Nina
    Lo, Mimi
    Martin III, Thomas
    Wolf, Jeffrey L.
    Chung, Alfred
    Arora, Shagun
    Huang, Chiung-Yu
    Wong, Sandy W.
    LEUKEMIA & LYMPHOMA, 2023,
  • [30] Impact of Corticosteroids on Efficacy of BCMA Targeted CAR-T Therapy in Multiple Myeloma
    Duvalyan, Eva
    Lo, Mimi
    Martin, Thomas
    Wolf, Jeffrey L.
    Chung, Alfred
    Arora, Shagun
    Shah, Nina
    Huang, Chiung-Yu
    Wong, Sandy W.
    BLOOD, 2021, 138